Sign In
Buy CAPR
$3.85
-0.240 (-5.87%)
At Close: Aug 10, 2026
ATLANTA, July 31, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor”) (NASDAQ: CAPR). The lawsuit alleges that Defendants ma
CAPR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Capricor (CAPR)
11:00am, Friday, 31'st Jul 2026
Capricor (NASDAQ: CAPR) shares collapsed 60% to 70% on July 27, 2026 after FDA staff briefing documents raised significant concerns regarding the evidence suppo
CAPR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Capricor (CAPR)
10:07am, Friday, 31'st Jul 2026
NEW YORK--(BUSINESS WIRE)--Capricor (NASDAQ: CAPR) shares collapsed 60% to 70% on July 27, 2026 after FDA staff briefing documents raised significant concerns regarding the evidence supporting Deramio
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Capricor Therapeutics, Inc. (âCaprico
BENSALEM, Pa.--(BUSINESS WIRE)--Securities fraud class action filed about Deramiocel BLA. Contact Howard Smith, Esq. before 9/28/26.
LOS ANGELES, July 31, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Ca
CAPR INVESTIGATION: Block & Leviton Seeks to Speak With Capricor Therapeutics Investors
09:00am, Friday, 31'st Jul 2026
Boston, Massachusetts--(Newsfile Corp. - July 31, 2026) - Block & Leviton is investigating Capricor Therapeutics (NASDAQ: CAPR) for potential securities law violations. Investors who have lost money i
NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Capricor Therapeutics, Inc. (NASDAQ:CAPR) for potential securities
CAPR CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Capricor Therapeutics, Inc.
02:00am, Friday, 31'st Jul 2026
LOS ANGELES--(BUSINESS WIRE)--CAPR CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Capricor Therapeutics, Inc.
CAPR CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit on Behalf of Capricor Therapeutics, Inc.
10:00pm, Thursday, 30'th Jul 2026
[url="]Glancy Prongay Wolke and Rotter LLP[/url] (âGPWRâ) announces that it has filed a class action lawsuit in the United States District Court for the South
CAPR CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit on Behalf of Capricor Therapeutics, Inc.
09:49pm, Thursday, 30'th Jul 2026
LOS ANGELES--(BUSINESS WIRE)--GPWR files securities fraud class action on behalf of CAPR investors. Contact firm before 9/28/26.
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Capricor The
LOS ANGELES, July 30, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz announces an investigation of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) on behalf
BENSALEM, Pa., July 30, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith announces a continuing investigation on behalf of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NAS
CAPR INVESTOR ALERT: Investigation of Capricor Therapeutics, Inc. Announced by Holzer & Holzer, LLC
01:52pm, Thursday, 30'th Jul 2026
ATLANTA, July 30, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) complied with federal securiti
